The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) Stock Competitors & Peer Comparison
See HGH's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Insurance - Diversified Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HGH and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HGH | $25.01 | +0.02% | 0 | -3.09 | -$8.08 | N/A |
| BRK-B | $529.42 | +1.46% | 1.1T | 17.66 | $29.98 | N/A |
| BRK-A | $793,815.00 | +1.76% | 1.1T | 24.64 | $32,096.47 | N/A |
| AIG-PA | $62.68 | +6.02% | 112.5B | 5.48 | $11.44 | +2.40% |
| AEH | $25.67 | +0.00% | 52.5B | 19.37 | $1.33 | +4.83% |
| AED | $25.52 | +0.00% | 52.2B | 19.26 | $1.33 | +4.83% |
| AEB | $25.01 | -0.08% | 51.1B | 18.88 | $1.33 | +4.83% |
| SLF | $82.63 | +0.88% | 45.8B | 15.22 | $5.43 | +3.22% |
| PFH | $15.88 | +0.06% | 41.3B | 1.05 | $15.04 | +4.52% |
| AIG | $77.61 | -1.49% | 41.1B | 9.61 | $8.08 | +2.40% |
Stock Comparison
Berkshire Hathaway Inc. (NYSE: BRK-B)
HGH vs BRK-B Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, BRK-B has a market cap of 1.1T. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while BRK-B trades at $529.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas BRK-B's P/E ratio is 17.66. In terms of profitability, HGH's ROE is +0.04%, compared to BRK-B's ROE of +0.12%. Regarding short-term risk, HGH is less volatile compared to BRK-B. This indicates lower risk in terms of short-term price fluctuations for HGH.Check BRK-B's competition here
Berkshire Hathaway Inc. (NYSE: BRK-A)
HGH vs BRK-A Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, BRK-A has a market cap of 1.1T. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while BRK-A trades at $793,815.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas BRK-A's P/E ratio is 24.64. In terms of profitability, HGH's ROE is +0.04%, compared to BRK-A's ROE of +0.12%. Regarding short-term risk, HGH is less volatile compared to BRK-A. This indicates lower risk in terms of short-term price fluctuations for HGH.Check BRK-A's competition here
American International Group, Inc. (NYSE: AIG-PA)
HGH vs AIG-PA Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AIG-PA has a market cap of 112.5B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AIG-PA trades at $62.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AIG-PA's P/E ratio is 5.48. In terms of profitability, HGH's ROE is +0.04%, compared to AIG-PA's ROE of +0.03%. Regarding short-term risk, HGH is less volatile compared to AIG-PA. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AIG-PA's competition here
Aegon N.V. PRP CP SEC 6.375 (NYSE: AEH)
HGH vs AEH Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AEH has a market cap of 52.5B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AEH trades at $25.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AEH's P/E ratio is 19.37. In terms of profitability, HGH's ROE is +0.04%, compared to AEH's ROE of +0.12%. Regarding short-term risk, HGH is less volatile compared to AEH. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AEH's competition here
Aegon N.V. PERP CAP SECS (NYSE: AED)
HGH vs AED Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AED has a market cap of 52.2B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AED trades at $25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AED's P/E ratio is 19.26. In terms of profitability, HGH's ROE is +0.04%, compared to AED's ROE of +0.12%. Regarding short-term risk, HGH is less volatile compared to AED. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AED's competition here
Aegon N.V. PERP CAP FLTG RT (NYSE: AEB)
HGH vs AEB Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AEB has a market cap of 51.1B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AEB trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AEB's P/E ratio is 18.88. In terms of profitability, HGH's ROE is +0.04%, compared to AEB's ROE of +0.12%. Regarding short-term risk, HGH is less volatile compared to AEB. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AEB's competition here
Sun Life Financial Inc. (NYSE: SLF)
HGH vs SLF Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, SLF has a market cap of 45.8B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while SLF trades at $82.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas SLF's P/E ratio is 15.22. In terms of profitability, HGH's ROE is +0.04%, compared to SLF's ROE of +0.14%. Regarding short-term risk, HGH is less volatile compared to SLF. This indicates lower risk in terms of short-term price fluctuations for HGH.Check SLF's competition here
Prudential Financial, Inc. 4.125% Junior Subordinated Notes due 2060 (NYSE: PFH)
HGH vs PFH Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, PFH has a market cap of 41.3B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while PFH trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas PFH's P/E ratio is 1.05. In terms of profitability, HGH's ROE is +0.04%, compared to PFH's ROE of +0.12%. Regarding short-term risk, HGH is less volatile compared to PFH. This indicates lower risk in terms of short-term price fluctuations for HGH.Check PFH's competition here
American International Group, Inc. (NYSE: AIG)
HGH vs AIG Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AIG has a market cap of 41.1B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AIG trades at $77.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AIG's P/E ratio is 9.61. In terms of profitability, HGH's ROE is +0.04%, compared to AIG's ROE of +0.03%. Regarding short-term risk, HGH is less volatile compared to AIG. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AIG's competition here
The Hartford Insurance Group, Inc. (NYSE: HIG)
HGH vs HIG Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, HIG has a market cap of 38.7B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while HIG trades at $141.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas HIG's P/E ratio is 9.84. In terms of profitability, HGH's ROE is +0.04%, compared to HIG's ROE of +0.23%. Regarding short-term risk, HGH is less volatile compared to HIG. This indicates lower risk in terms of short-term price fluctuations for HGH.Check HIG's competition here
Arch Capital Group Ltd. (NASDAQ: ACGLO)
HGH vs ACGLO Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ACGLO has a market cap of 34.5B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ACGLO trades at $19.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ACGLO's P/E ratio is 1.57. In terms of profitability, HGH's ROE is +0.04%, compared to ACGLO's ROE of +0.20%. Regarding short-term risk, HGH is less volatile compared to ACGLO. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ACGLO's competition here
Arch Capital Group Ltd. (NASDAQ: ACGLN)
HGH vs ACGLN Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ACGLN has a market cap of 34.5B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ACGLN trades at $16.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ACGLN's P/E ratio is 1.39. In terms of profitability, HGH's ROE is +0.04%, compared to ACGLN's ROE of +0.20%. Regarding short-term risk, HGH is less volatile compared to ACGLN. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ACGLN's competition here
Arch Capital Group Ltd. (NASDAQ: ACGL)
HGH vs ACGL Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ACGL has a market cap of 34.3B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ACGL trades at $98.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ACGL's P/E ratio is 9.07. In terms of profitability, HGH's ROE is +0.04%, compared to ACGL's ROE of +0.20%. Regarding short-term risk, HGH is less volatile compared to ACGL. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ACGL's competition here
Athene Holding Ltd. (NYSE: ATH)
HGH vs ATH Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ATH has a market cap of 19.8B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ATH trades at $83.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ATH's P/E ratio is 4.42. In terms of profitability, HGH's ROE is +0.04%, compared to ATH's ROE of +0.01%. Regarding short-term risk, HGH is less volatile compared to ATH. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ATH's competition here
Reinsurance Group of America, Incorporated (NYSE: RZC)
HGH vs RZC Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, RZC has a market cap of 15.5B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while RZC trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas RZC's P/E ratio is 5.48. In terms of profitability, HGH's ROE is +0.04%, compared to RZC's ROE of +0.05%. Regarding short-term risk, HGH is less volatile compared to RZC. This indicates lower risk in terms of short-term price fluctuations for HGH.Check RZC's competition here
Arch Capital Group Ltd. (NASDAQ: ACGLP)
HGH vs ACGLP Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ACGLP has a market cap of 15.2B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ACGLP trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ACGLP's P/E ratio is 5.03. In terms of profitability, HGH's ROE is +0.04%, compared to ACGLP's ROE of +0.20%. Regarding short-term risk, HGH is less volatile compared to ACGLP. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ACGLP's competition here
Brookfield Wealth Solutions Ltd. (NYSE: BNT)
HGH vs BNT Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, BNT has a market cap of 14.8B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while BNT trades at $44.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas BNT's P/E ratio is 178.56. In terms of profitability, HGH's ROE is +0.04%, compared to BNT's ROE of +0.03%. Regarding short-term risk, HGH is less volatile compared to BNT. This indicates lower risk in terms of short-term price fluctuations for HGH.Check BNT's competition here
Assurant, Inc. 5.25% Subordinat (NYSE: AIZN)
HGH vs AIZN Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AIZN has a market cap of 14.6B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AIZN trades at $18.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AIZN's P/E ratio is 0.79. In terms of profitability, HGH's ROE is +0.04%, compared to AIZN's ROE of +0.18%. Regarding short-term risk, HGH is less volatile compared to AIZN. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AIZN's competition here
Equitable Holdings, Inc. (NYSE: EQH)
HGH vs EQH Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, EQH has a market cap of 14.4B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while EQH trades at $52.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas EQH's P/E ratio is 8.03. In terms of profitability, HGH's ROE is +0.04%, compared to EQH's ROE of +8.46%. Regarding short-term risk, HGH is less volatile compared to EQH. This indicates lower risk in terms of short-term price fluctuations for HGH.Check EQH's competition here
Aegon Ltd. (NYSE: AEG)
HGH vs AEG Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AEG has a market cap of 14.2B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AEG trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AEG's P/E ratio is 13.41. In terms of profitability, HGH's ROE is +0.04%, compared to AEG's ROE of +0.12%. Regarding short-term risk, HGH is less volatile compared to AEG. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AEG's competition here
Unum Group 6.250% JR NT58 (NYSE: UNMA)
HGH vs UNMA Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, UNMA has a market cap of 14.2B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while UNMA trades at $21.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas UNMA's P/E ratio is 2.81. In terms of profitability, HGH's ROE is +0.04%, compared to UNMA's ROE of +0.06%. Regarding short-term risk, HGH is less volatile compared to UNMA. This indicates lower risk in terms of short-term price fluctuations for HGH.Check UNMA's competition here
Equitable Holdings, Inc. (NYSE: EQH-PC)
HGH vs EQH-PC Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, EQH-PC has a market cap of 14B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while EQH-PC trades at $16.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas EQH-PC's P/E ratio is 22.18. In terms of profitability, HGH's ROE is +0.04%, compared to EQH-PC's ROE of +8.46%. Regarding short-term risk, HGH is less volatile compared to EQH-PC. This indicates lower risk in terms of short-term price fluctuations for HGH.Check EQH-PC's competition here
Equitable Holdings, Inc. (NYSE: EQH-PA)
HGH vs EQH-PA Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, EQH-PA has a market cap of 13.7B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while EQH-PA trades at $18.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas EQH-PA's P/E ratio is 25.84. In terms of profitability, HGH's ROE is +0.04%, compared to EQH-PA's ROE of +8.46%. Regarding short-term risk, HGH is less volatile compared to EQH-PA. This indicates lower risk in terms of short-term price fluctuations for HGH.Check EQH-PA's competition here
Old Republic International Corporation (NYSE: ORI)
HGH vs ORI Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ORI has a market cap of 10.3B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ORI trades at $42.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ORI's P/E ratio is 12.64. In terms of profitability, HGH's ROE is +0.04%, compared to ORI's ROE of +0.19%. Regarding short-term risk, HGH is less volatile compared to ORI. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ORI's competition here
AXIS Capital Holdings Limited (NYSE: AXS)
HGH vs AXS Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AXS has a market cap of 7.4B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AXS trades at $101.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AXS's P/E ratio is 7.70. In terms of profitability, HGH's ROE is +0.04%, compared to AXS's ROE of +0.19%. Regarding short-term risk, HGH is less volatile compared to AXS. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AXS's competition here
AXIS Capital Holdings Limited (NYSE: AXS-PE)
HGH vs AXS-PE Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AXS-PE has a market cap of 6.9B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AXS-PE trades at $18.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AXS-PE's P/E ratio is 1.41. In terms of profitability, HGH's ROE is +0.04%, compared to AXS-PE's ROE of +0.19%. Regarding short-term risk, HGH is less volatile compared to AXS-PE. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AXS-PE's competition here
Enstar Group Limited (NASDAQ: ESGRP)
HGH vs ESGRP Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ESGRP has a market cap of 5.3B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ESGRP trades at $20.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ESGRP's P/E ratio is 0.64. In terms of profitability, HGH's ROE is +0.04%, compared to ESGRP's ROE of +0.10%. Regarding short-term risk, HGH is similarly volatile compared to ESGRP. This indicates similar risk in terms of short-term price fluctuations for HGH.Check ESGRP's competition here
White Mountains Insurance Group, Ltd. (NYSE: WTM)
HGH vs WTM Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, WTM has a market cap of 5.2B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while WTM trades at $2,109.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas WTM's P/E ratio is 21.06. In terms of profitability, HGH's ROE is +0.04%, compared to WTM's ROE of +0.22%. Regarding short-term risk, HGH is less volatile compared to WTM. This indicates lower risk in terms of short-term price fluctuations for HGH.Check WTM's competition here
CNO Financial Group, Inc. 5.125 (NYSE: CNO-PA)
HGH vs CNO-PA Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, CNO-PA has a market cap of 5.2B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while CNO-PA trades at $16.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas CNO-PA's P/E ratio is 5.52. In terms of profitability, HGH's ROE is +0.04%, compared to CNO-PA's ROE of +0.11%. Regarding short-term risk, HGH is less volatile compared to CNO-PA. This indicates lower risk in terms of short-term price fluctuations for HGH.Check CNO-PA's competition here
Athene Holding Ltd. (NYSE: ATH-PC)
HGH vs ATH-PC Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ATH-PC has a market cap of 5.1B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ATH-PC trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ATH-PC's P/E ratio is 3.14. In terms of profitability, HGH's ROE is +0.04%, compared to ATH-PC's ROE of +0.01%. Regarding short-term risk, HGH is less volatile compared to ATH-PC. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ATH-PC's competition here
Enstar Group Limited (NASDAQ: ESGR)
HGH vs ESGR Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ESGR has a market cap of 5B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ESGR trades at $337.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ESGR's P/E ratio is 10.83. In terms of profitability, HGH's ROE is +0.04%, compared to ESGR's ROE of +0.10%. Regarding short-term risk, HGH is similarly volatile compared to ESGR. This indicates similar risk in terms of short-term price fluctuations for HGH.Check ESGR's competition here
Enstar Group Limited (NASDAQ: ESGRO)
HGH vs ESGRO Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ESGRO has a market cap of 5B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ESGRO trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ESGRO's P/E ratio is 0.57. In terms of profitability, HGH's ROE is +0.04%, compared to ESGRO's ROE of +0.10%. Regarding short-term risk, HGH is similarly volatile compared to ESGRO. This indicates similar risk in terms of short-term price fluctuations for HGH.Check ESGRO's competition here
Genworth Financial, Inc. (NYSE: GNW)
HGH vs GNW Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, GNW has a market cap of 3.7B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while GNW trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas GNW's P/E ratio is 15.53. In terms of profitability, HGH's ROE is +0.04%, compared to GNW's ROE of +0.02%. Regarding short-term risk, HGH is less volatile compared to GNW. This indicates lower risk in terms of short-term price fluctuations for HGH.Check GNW's competition here
Aspen Insurance Holdings Limited (NYSE: AHL-PE)
HGH vs AHL-PE Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AHL-PE has a market cap of 3.4B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AHL-PE trades at $18.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AHL-PE's P/E ratio is 7.79. In terms of profitability, HGH's ROE is +0.04%, compared to AHL-PE's ROE of +0.06%. Regarding short-term risk, HGH is less volatile compared to AHL-PE. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AHL-PE's competition here
Fidelis Insurance Holdings Limited (NYSE: FIHL)
HGH vs FIHL Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, FIHL has a market cap of 2.4B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while FIHL trades at $23.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas FIHL's P/E ratio is 10.93. In terms of profitability, HGH's ROE is +0.04%, compared to FIHL's ROE of +0.16%. Regarding short-term risk, HGH is less volatile compared to FIHL. This indicates lower risk in terms of short-term price fluctuations for HGH.Check FIHL's competition here
Aspen Insurance Holdings Limited (NYSE: AHL-PD)
HGH vs AHL-PD Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AHL-PD has a market cap of 2.4B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AHL-PD trades at $18.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AHL-PD's P/E ratio is 6.02. In terms of profitability, HGH's ROE is +0.04%, compared to AHL-PD's ROE of +0.06%. Regarding short-term risk, HGH is less volatile compared to AHL-PD. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AHL-PD's competition here
Goosehead Insurance, Inc (NASDAQ: GSHD)
HGH vs GSHD Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, GSHD has a market cap of 2.4B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while GSHD trades at $64.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas GSHD's P/E ratio is 34.15. In terms of profitability, HGH's ROE is +0.04%, compared to GSHD's ROE of -0.33%. Regarding short-term risk, HGH is less volatile compared to GSHD. This indicates lower risk in terms of short-term price fluctuations for HGH.Check GSHD's competition here
Pelagos Insurance Capital Limit (NYSE: PLGO)
HGH vs PLGO Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, PLGO has a market cap of 2.1B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while PLGO trades at $24.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas PLGO's P/E ratio is 7.32. In terms of profitability, HGH's ROE is +0.04%, compared to PLGO's ROE of +0.16%. Regarding short-term risk, HGH is less volatile compared to PLGO. This indicates lower risk in terms of short-term price fluctuations for HGH.Check PLGO's competition here
Exzeo Group, Inc. (NYSE: XZO)
HGH vs XZO Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, XZO has a market cap of 1.4B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while XZO trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas XZO's P/E ratio is 16.19. In terms of profitability, HGH's ROE is +0.04%, compared to XZO's ROE of +0.39%. Regarding short-term risk, HGH is less volatile compared to XZO. This indicates lower risk in terms of short-term price fluctuations for HGH.Check XZO's competition here
International General Insurance Holdings Ltd. (NASDAQ: IGIC)
HGH vs IGIC Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, IGIC has a market cap of 1.1B. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while IGIC trades at $26.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas IGIC's P/E ratio is 9.91. In terms of profitability, HGH's ROE is +0.04%, compared to IGIC's ROE of +0.16%. Regarding short-term risk, HGH is less volatile compared to IGIC. This indicates lower risk in terms of short-term price fluctuations for HGH.Check IGIC's competition here
Argo Group US, Inc. 6.5% SR NTS 42 (NYSE: ARGD)
HGH vs ARGD Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ARGD has a market cap of 874.2M. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ARGD trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ARGD's P/E ratio is N/A. In terms of profitability, HGH's ROE is +0.04%, compared to ARGD's ROE of +0.05%. Regarding short-term risk, HGH is less volatile compared to ARGD. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ARGD's competition here
Kingsway Corporation (NYSE: KWY)
HGH vs KWY Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, KWY has a market cap of 291.5M. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while KWY trades at $10.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas KWY's P/E ratio is -100.70. In terms of profitability, HGH's ROE is +0.04%, compared to KWY's ROE of -0.31%. Regarding short-term risk, HGH is less volatile compared to KWY. This indicates lower risk in terms of short-term price fluctuations for HGH.Check KWY's competition here
Yuanbao Inc. American Depositary Shares (NASDAQ: YB)
HGH vs YB Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, YB has a market cap of 106.3M. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while YB trades at $13.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas YB's P/E ratio is 3.20. In terms of profitability, HGH's ROE is +0.04%, compared to YB's ROE of +0.44%. Regarding short-term risk, HGH is less volatile compared to YB. This indicates lower risk in terms of short-term price fluctuations for HGH.Check YB's competition here
Kestrel Group Ltd (NASDAQ: KG)
HGH vs KG Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, KG has a market cap of 69.2M. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while KG trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas KG's P/E ratio is -1.75. In terms of profitability, HGH's ROE is +0.04%, compared to KG's ROE of -0.30%. Regarding short-term risk, HGH is less volatile compared to KG. This indicates lower risk in terms of short-term price fluctuations for HGH.Check KG's competition here
XChange TEC.INC (NASDAQ: XHG)
HGH vs XHG Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, XHG has a market cap of 49.1M. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while XHG trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas XHG's P/E ratio is -0.02. In terms of profitability, HGH's ROE is +0.04%, compared to XHG's ROE of +0.10%. Regarding short-term risk, HGH is less volatile compared to XHG. This indicates lower risk in terms of short-term price fluctuations for HGH.Check XHG's competition here
FG Financial Group, Inc. (NASDAQ: FGFPP)
HGH vs FGFPP Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, FGFPP has a market cap of 25.9M. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while FGFPP trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas FGFPP's P/E ratio is -1.59. In terms of profitability, HGH's ROE is +0.04%, compared to FGFPP's ROE of -0.72%. Regarding short-term risk, HGH is less volatile compared to FGFPP. This indicates lower risk in terms of short-term price fluctuations for HGH.Check FGFPP's competition here
International General Insurance Holdings Ltd. (NASDAQ: IGICW)
HGH vs IGICW Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, IGICW has a market cap of 0. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while IGICW trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas IGICW's P/E ratio is N/A. In terms of profitability, HGH's ROE is +0.04%, compared to IGICW's ROE of +0.16%. Regarding short-term risk, HGH is less volatile compared to IGICW. This indicates lower risk in terms of short-term price fluctuations for HGH.Check IGICW's competition here
American National Group, Inc. (NASDAQ: ANAT)
HGH vs ANAT Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, ANAT has a market cap of 0. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while ANAT trades at $188.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas ANAT's P/E ratio is 6.73. In terms of profitability, HGH's ROE is +0.04%, compared to ANAT's ROE of +0.10%. Regarding short-term risk, HGH is less volatile compared to ANAT. This indicates lower risk in terms of short-term price fluctuations for HGH.Check ANAT's competition here
Watford Holdings Ltd. (NASDAQ: WTREP)
HGH vs WTREP Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, WTREP has a market cap of 0. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while WTREP trades at $25.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas WTREP's P/E ratio is 1.35. In terms of profitability, HGH's ROE is +0.04%, compared to WTREP's ROE of +0.00%. Regarding short-term risk, HGH is less volatile compared to WTREP. This indicates lower risk in terms of short-term price fluctuations for HGH.Check WTREP's competition here
American Independence Corp. (NASDAQ: AMIC)
HGH vs AMIC Comparison August 2026
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (NYSE: HGH) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HGH stands at 0. In comparison, AMIC has a market cap of 0. Regarding current trading prices, HGH is priced at $25.01 on the NYSE, while AMIC trades at $24.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HGH currently has a P/E ratio of -3.09, whereas AMIC's P/E ratio is 1.70. In terms of profitability, HGH's ROE is +0.04%, compared to AMIC's ROE of +0.04%. Regarding short-term risk, HGH is less volatile compared to AMIC. This indicates lower risk in terms of short-term price fluctuations for HGH.Check AMIC's competition here